Circulating Tumor Cells (CTC) Market Overview
The Circulating Tumor Cells (CTC) Market was valued at USD 6.27 billion in 2024 and is projected to reach USD 12.5 billion by 2035, growing at a CAGR of 6.4%. CTCs are cancer cells that detach from primary tumors and enter the bloodstream, serving as critical biomarkers for cancer diagnosis, prognosis, and treatment monitoring. These cells enable non-invasive liquid biopsy approaches that...
0 Comments 0 Shares 87 Views 0 Reviews